BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Russian Patent For Cyclosporin Neuroprotection Granted To Maas BiolAB


10/19/2005 5:10:02 PM

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Feb. 17, 2004--Maas BiolAB was granted Cyclosporin Neuroprotection patent number 2194527 by RosPatent, the Russian Patent Office. Russia has a population of 141 million people. This Russian patent joins Maas patents in North America (USA, Canada, Mexico), Europe (Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Monaco, Netherlands, Portugal, Slovenia, Spain, Sweden, Switzerland, United Kingdom), Africa (Ghana, Kenya, Lesotho, Malawi, Sudan, Swaziland, Uganda, Zimbabwe) and the Antipodes (Australia, New Zealand).

Maas BiolAB is a privately held neuropharmaceutical corporation based in Albuquerque, NM, USA developing cyclosporin drugs for the neurodegenerative diseases of Alzheimer's, Parkinson's, Huntington's and amyotrophic lateral sclerosis. NeuroPharma AB is a Maas corporate and research partner developing NeuroSTAT(TM), a proprietary, non-toxic intravenous cyclosporin formula for traumatic brain injury, spinal cord injury and stroke. NeuroPharma AB is located in the Medicon Valley biotechnology center of Sweden, with close ties to the Wallenberg Neuroscience Center, Lund University. For more information please visit www.maasbiolab.com.

Maas BiolAB, LLC 1934 Quail Run Loop NE Albuquerque, NM 87122 USA +1-505-797-1020 tel +1-505-797-1024 fax

NeuroPharma AB Magle Stora Kyrkogata 6 223 50 Lund, Sweden

Contact:

Maas BiolAB, LLC Marcus Keep M.D., 505-797-1020 or

NeuroPharma AB Greg Batcheller, +46-46-157763

Source: Maas BiolAB



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES